| (210) | Number of the EPO application | 15808300 |
| (220) | Filing date of the EPO application | 2015.11.16 |
| (80) | EPO patent specification publication (B) | EPB nr. 11/2021, 2021.03.17 |
| (110) | EPO patent number | 3218380 |
| (21) | Number of the application | e 2017 0094 |
| (71) | Name(s) of applicant(s), code of the country | Array Biopharma, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | ARRIGO Alisha B., US;
JUENGST Derrick, US;
SHAH Khalid, US; |
| (73) | Name(s) of owner(s), code of the country | ARRAY Biopharma Inc., US; |
| (54) | Title of the invention | PREPARATION OF A CRYSTALLINE FORM OF (S)-N-(5-((R)-2-(2,5-DIFLUOROPHENYL)-PYRROLIDIN-1-YL)-PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDINE-1-CARBOXAMIDE HYDROGEN SULFATE |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07D 487/04 (2006.01.01); A61K 31/519 (2006.01.01); A61P 35/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2017.10.31 |
| (30) | Priority | 201462080374 P, 2014.11.16, US; 201562169545 P, 2015.06.01, US |
| (86) | International application | PCT/US2015/060953, 2015.11.16 |
| (87) | International publication | WO 2016/077841, 2016.05.19 |